ASCLF Overview
Upcoming Projects (ASCLF)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ASCLF)
-
Examining the Phase 3 Results for denifanstat for the treatment of moderate-to-severe acne from Sagimet's partner Ascletis
Tickers: SGMT, ASCLF
Executed On: Jun 11, 2025 at 04:15 PM EDT -
A Third Look: Discussing the interim results from the first two cohorts of the Phase Ib multiple ascending dose (MAD) study, of ASC30 oral once-daily tablet in patients with obesity
Ticker: ASCLF
Executed On: Apr 09, 2025 at 04:00 PM EDT -
A Second Look: Discussing the interim results from the first two cohorts of the Phase Ib multiple ascending dose (MAD) study, of ASC30 oral once-daily tablet in patients with obesity
Ticker: ASCLF
Executed On: Mar 12, 2025 at 10:00 AM EDT -
Discussing the interim results from the first two cohorts of the Phase Ib multiple ascending dose (MAD) study, of ASC30 oral once-daily tablet in patients with obesity
Ticker: ASCLF
Executed On: Mar 10, 2025 at 02:00 PM EDT
Upcoming & Overdue Catalysts (ASCLF)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ASCLF)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
